 Vital Capacity
"Vital Capacity" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The volume of air that is exhaled by a maximal expiration following a maximal inspiration.
| Descriptor ID |
D014797
|
| MeSH Number(s) |
E01.370.386.700.485.750.900 G09.772.850.970
|
| Concept/Terms |
Vital Capacity- Vital Capacity
- Capacities, Vital
- Capacity, Vital
- Vital Capacities
Forced Vital Capacity- Forced Vital Capacity
- Capacities, Forced Vital
- Capacity, Forced Vital
- Forced Vital Capacities
- Vital Capacities, Forced
- Vital Capacity, Forced
|
Below are MeSH descriptors whose meaning is more general than "Vital Capacity".
Below are MeSH descriptors whose meaning is more specific than "Vital Capacity".
This graph shows the total number of publications written about "Vital Capacity" by people in this website by year, and whether "Vital Capacity" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 | | 1997 | 0 | 3 | 3 | | 1998 | 0 | 1 | 1 | | 2000 | 0 | 4 | 4 | | 2002 | 0 | 1 | 1 | | 2003 | 0 | 2 | 2 | | 2004 | 0 | 2 | 2 | | 2005 | 0 | 4 | 4 | | 2006 | 0 | 1 | 1 | | 2007 | 0 | 1 | 1 | | 2008 | 0 | 5 | 5 | | 2009 | 0 | 9 | 9 | | 2010 | 1 | 5 | 6 | | 2011 | 2 | 6 | 8 | | 2012 | 1 | 10 | 11 | | 2013 | 0 | 10 | 10 | | 2014 | 4 | 9 | 13 | | 2015 | 2 | 11 | 13 | | 2016 | 2 | 6 | 8 | | 2017 | 2 | 11 | 13 | | 2018 | 0 | 10 | 10 | | 2019 | 0 | 8 | 8 | | 2020 | 1 | 8 | 9 | | 2021 | 1 | 11 | 12 | | 2022 | 1 | 7 | 8 | | 2023 | 0 | 13 | 13 | | 2024 | 0 | 9 | 9 | | 2025 | 0 | 11 | 11 | | 2026 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Vital Capacity" by people in Profiles.
-
Tepper RS, Wagner BD, Bjerregaard J, Tiller C, Amos L, Sokol G, Adducci D, Abman SH. Differential Trajectories of Airway and Parenchymal Function in Infants Born Preterm. J Pediatr. 2026 Jun; 293:115025.
-
El Husseini K, Lee JS, Juge PA, Ebstein E, Ottaviani S, Borie R, Bancal C, Debray MP, Kannengiesser C, Ba I, Marchand-Adam S, Richez C, Nunes H, Avouac J, Flipo RM, Wemeau L, Boissier MC, Schaeverbeke T, Saidenberg Kermanac'h N, Kawano-Dourado L, Cottin V, Wolters PJ, Granger B, Dieudé P, Crestani B. Short telomere length is associated with accelerated lung disease progression in rheumatoid arthritis-associated interstitial lung disease. Eur Respir J. 2025 Dec; 66(6).
-
Bae SS, Markovic D, Saygin D, Sullivan D, Yamaguchi K, Moghadam-Kia S, Oddis CV, Abtin F, Kim GHJ, Marder G, Venuturupalli S, Dellaripa PF, Danoff S, Doyle T, Hunninghake G, Lee JS, Falk J, Johnson C, Goldin J, Tashkin D, Charles-Schoeman C, Aggarwal R. Associations between 6-minute walk distance and physiologic measures and clinical outcomes in myositis-associated interstitial lung disease. Rheumatology (Oxford). 2025 Dec 01; 64(SI):SI79-SI87.
-
Harris KJR, Ludtke EA, Goldberg B, McCall NN, Hewlett JC, Wilfong EM. Tacrolimus as first-line therapy in a US cohort of idiopathic inflammatory myopathies related interstitial lung disease. Rheumatology (Oxford). 2025 Dec 01; 64(SI):SI179-SI183.
-
Aggarwal R, Pongtarakulpanit N, Sullivan DI, Moghadam-Kia S, Bae SS, Wilkerson J, Saygin D, Marder G, Venuturupalli S, Dellaripa PF, Danoff SK, Doyle T, Hunninghake GM, Lee JS, Fischer A, Falk J, Johnson C, Koontz D, Ascherman DP, Oddis CV. Abatacept for the treatment of myositis-associated interstitial lung disease. Rheumatology (Oxford). 2025 Dec 01; 64(SI):SI156-SI168.
-
Kim JS, Pugashetti J, Ma SF, Huang Y, Podolanczuk AJ, Lynch DA, Oh A, Mychaleckyj J, Manichaikul A, Rich S, Chua F, Adams TM, Flaherty KR, Lee JS, Lasky JA, Raghu G, Murray S, Spino C, Martinez FJ, Noth I, Humphries SM, Adegunsoye A, Molyneaux PL, Oldham JM, Newton CA. Associations of interstitial lung disease subtype and CT pattern with lung function and survival. Thorax. 2025 Nov 14; 80(12):927-934.
-
Koslow M, Baraghoshi D, Swigris JJ, Brown KK, Fernández Pérez ER, Huie TJ, Keith RC, Mohning MP, Solomon JJ, Yunt ZX, Manco G, Lynch DA, Humphries SM. One-Year Change in Quantitative Computed Tomography Is Associated with Meaningful Outcomes in Fibrotic Lung Disease. Am J Respir Crit Care Med. 2025 Oct; 211(10):1775-1784.
-
Matson SM, Kim GHJ, Humphries SM, Roth MD, Goldin J, Tashkin DP, Leng M, England BR, Lee JS, Volkmann ER. Impact of quantitative radiological features of interstitial lung disease on immunomodulatory treatment response in three autoimmune interstitial lung disease cohorts. Thorax. 2025 07 15; 80(8):540-546.
-
Knox-Brown B, Potts J, Franssen FME, Nielsen R, Denguezli M, Rotevatn AØ, Juvekar SK, Cherkaski HH, Studnicka M, Sylvester KP, Mortimer K, Bateman ED, Janson C, Malinovschi A, Seemungal T, Koul P, Mannino D, Mahesh PA, Jogi R, Mejza F, Al Ghobain M, Paraguas SNM, Welte T, Wouters E, Gislason T, Harrabi I, Dias H, Obaseki DO, Kocabas A, Barbara C, Cardoso J, Agarwal D, Nafees AA, Rodrigues F, Garcia-Larsen V, Erhabor GE, Loh LC, Amaral AFS. Concordance between FVC and FEV6 for identifying chronic airflow obstruction and spirometric restriction in the Burden of Obstructive Lung Disease (BOLD) study. BMJ Open Respir Res. 2025 Jul 13; 12(1).
-
Mohning MP, Krefft SD. Use of Spirometry in Pulmonary Function Evaluation. Clin Chest Med. 2025 Sep; 46(3):401-412.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|